The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration. Marquis KA, Everett JK, Cantu VA, McFarland AG, et al. AIDS Res Hum Retroviruses 2023 Apr 26. doi: 10.1089/AID.2022.0161.

Read + Share

Amedeo Smart

Independent Medical Education

Marquis KA, Everett JK, Cantu VA, McFarland AG, et al. The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration. AIDS Res Hum Retroviruses 2023 Apr 26. doi: 10.1089/AID.2022.0161.
PMID: 37125442